Meyer Children's Hospital IRCCS
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Meyer Children's Hospital IRCCS sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Meyer Children's Hospital IRCCS: 6 sponsored US clinical trials, 5 recruiting.
Meyer Children's Hospital IRCCS sponsors 6 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting. The most-studied condition in this pipeline is Eosinophilic Fasciitis, with 1 trials.
Upper-quartile sponsor footprint
Meyer Children's Hospital IRCCS sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
SLIT ABS: Study on Patients With Autoimmune Podocytopathy
NCT07516964
EFESO: Study on Juvenile Onset Eosinophilic Fasciitis
NCT07348263
Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia
NCT06921993
ECD-Score: a Study on Erdheim-Chester Disease
NCT07454343
RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
NCT06273748
Autoimmune Cytopenias as a Sign of Primary Immunodeficiency.
NCT06276036
Therapeutic Areas
What is open in the Meyer Children's Hospital IRCCS pipeline
5 recruiting of 6 indexed (83% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Eosinophilic Fasciitis (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Meyer Children's Hospital IRCCS: open-pipeline peers nationwide
Peers matched on 6 registered trials and 83% open enrollment, not the therapeutic-area sidebar.
Meyer Children's Hospital IRCCS sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 83% open enrollment (± trial volume)
- Centessa Pharmaceuticals (UK) Limited · 83% recruiting · 6 trials
- SystImmune · 83% recruiting · 6 trials
- Tyra Biosciences · 83% recruiting · 6 trials
- Johnson & Johnson Enterprise Innovation · 86% recruiting · 7 trials
Related
What to do with this Meyer Children's Hospital IRCCS page
6 registered trials is a research-attention snapshot, not an endorsement of Meyer Children's Hospital IRCCS or any single study.
- 5 of Meyer Children's Hospital IRCCS's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Eosinophilic Fasciitis is the condition Meyer Children's Hospital IRCCS studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Eosinophilic Fasciitis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Meyer Children's Hospital IRCCS pipeline card: 6 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.